Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy: Patient outcomes, rate of appropriate and inappropriate interventions, and complications
- 30 September 2013
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 166 (3), 496-502
- https://doi.org/10.1016/j.ahj.2013.06.009
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Reduction in Inappropriate Therapy and Mortality through ICD ProgrammingThe New England Journal of Medicine, 2012
- Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic CardiomyopathyCirculation: Heart Failure, 2012
- Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic CardiomyopathyJACC: Cardiovascular Imaging, 2012
- Cardiac Arrest during Long-Distance Running RacesThe New England Journal of Medicine, 2012
- Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2010
- Long-Term Outcome of Alcohol Septal Ablation in Patients With Obstructive Hypertrophic CardiomyopathyCirculation: Heart Failure, 2010
- Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseasesEuropean Heart Journal, 2007
- Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathyHeart, 2007
- Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathyThe American Journal of Cardiology, 2004
- A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery DiseaseThe New England Journal of Medicine, 1999